173 related articles for article (PubMed ID: 9269866)
1. Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin.
Davis DA; Kraus AL; Thompson GA; Olerich M; Odio MR
J Pharm Sci; 1997 Aug; 86(8):896-9. PubMed ID: 9269866
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of salicylic acid following topically applied salicylate derivatives.
Morra P; Bartle WR; Walker SE; Lee SN; Bowles SK; Reeves RA
Ann Pharmacother; 1996 Sep; 30(9):935-40. PubMed ID: 8876850
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD
Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265
[TBL] [Abstract][Full Text] [Related]
4. Determination of acetylsalicylic acid and salicylic acid in skin and plasma by high-performance liquid chromatography.
Pirola R; Bareggi SR; De Benedittis G
J Chromatogr B Biomed Sci Appl; 1998 Feb; 705(2):309-15. PubMed ID: 9521569
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of salicylic acid from acne treatment products into and through skin: role of solution and ingredient properties and relationships to irritation.
Rhein L; Chaudhuri B; Jivani N; Fares H; Davis A
J Cosmet Sci; 2004; 55(1):65-80. PubMed ID: 15037921
[TBL] [Abstract][Full Text] [Related]
6. Relative bioavailability of salicylic acid following dermal application of a 30% salicylic acid skin peel preparation.
Fung W; Orak D; Re TA; Haughey DB
J Pharm Sci; 2008 Mar; 97(3):1325-8. PubMed ID: 17694544
[TBL] [Abstract][Full Text] [Related]
7. Clinical evidence on the efficacy and safety of an antioxidant optimized 1.5% salicylic acid (SA) cream in the treatment of facial acne: an open, baseline-controlled clinical study.
Zheng Y; Wan M; Chen H; Ye C; Zhao Y; Yi J; Xia Y; Lai W
Skin Res Technol; 2013 May; 19(2):125-30. PubMed ID: 23331850
[TBL] [Abstract][Full Text] [Related]
8. Excellent clinical results with a new preparation for chemical peeling in acne: 30% salicylic acid in polyethylene glycol vehicle.
Dainichi T; Ueda S; Imayama S; Furue M
Dermatol Surg; 2008 Jul; 34(7):891-9; discussion 899. PubMed ID: 18363720
[TBL] [Abstract][Full Text] [Related]
9. Plasma acetylsalicylic acid and salicylic acid levels during aspirin provocation in aspirin-sensitive subjects.
Dahlén B; Boréus LO; Anderson P; Andersson R; Zetterström O
Allergy; 1994 Jan; 49(1):43-9. PubMed ID: 8198239
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic study of percutaneous absorption of salicylic acid from baths with salicylate methyl ester and salicylic acid].
Pratzel HG; Schubert E; Muhanna N
Z Rheumatol; 1990; 49(4):185-91. PubMed ID: 2238859
[TBL] [Abstract][Full Text] [Related]
11. Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers.
Day RO; Furst DE; Dromgoole SH; Paulus HE
Biopharm Drug Dispos; 1988; 9(3):273-83. PubMed ID: 3395669
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet.
Lücker PW; Wetzelsberger N; Schettler T; Rogalla K
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):805-11. PubMed ID: 1297896
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous absorption of salicylic acid, theophylline, 2, 4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo.
Wester RC; Melendres J; Sedik L; Maibach H; Riviere JE
Toxicol Appl Pharmacol; 1998 Jul; 151(1):159-65. PubMed ID: 9705899
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro.
Walters KA; Brain KR; Howes D; James VJ; Kraus AL; Teetsel NM; Toulon M; Watkinson AC; Gettings SD
Food Chem Toxicol; 1997 Dec; 35(12):1219-25. PubMed ID: 9449227
[TBL] [Abstract][Full Text] [Related]
15. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
[TBL] [Abstract][Full Text] [Related]
16. Topical bioavailability of methyl salicylate.
Roberts MS; Favretto WA; Meyer A; Reckmann M; Wongseelashote T
Aust N Z J Med; 1982 Jun; 12(3):303-5. PubMed ID: 6956302
[No Abstract] [Full Text] [Related]
17. Percutaneous absorption of salicylic acid--in vitro and in vivo studies.
Mateus R; Moore DJ; Hadgraft J; Lane ME
Int J Pharm; 2014 Nov; 475(1-2):471-4. PubMed ID: 25178827
[TBL] [Abstract][Full Text] [Related]
18. Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris.
Babayeva L; Akarsu S; Fetil E; Güneş AT
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):328-33. PubMed ID: 20666879
[TBL] [Abstract][Full Text] [Related]
19. Topical acetylsalicylic, salicylic acid and indomethacin suppress pain from experimental tissue acidosis in human skin.
Steen KH; Reeh PW; Kreysel HW
Pain; 1995 Sep; 62(3):339-347. PubMed ID: 8657434
[TBL] [Abstract][Full Text] [Related]
20. Distribution and keratolytic effect of salicylic acid and urea in human skin.
Lodén M; Boström P; Kneczke M
Skin Pharmacol; 1995; 8(4):173-8. PubMed ID: 7488393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
